Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-25
Closed -$2K 746
2023
Q3
$2K Hold
25
﹤0.01% 659
2023
Q2
$2K Hold
25
﹤0.01% 555
2023
Q1
$2K Hold
25
﹤0.01% 552
2022
Q4
$2K Hold
25
﹤0.01% 518
2022
Q3
$2K Hold
25
﹤0.01% 597
2022
Q2
$2K Hold
25
﹤0.01% 546
2022
Q1
$2K Hold
25
﹤0.01% 547
2021
Q4
$2K Hold
25
﹤0.01% 522
2021
Q3
$2K Hold
25
﹤0.01% 530
2021
Q2
$2K Hold
25
﹤0.01% 517
2021
Q1
$2K Hold
25
﹤0.01% 505
2020
Q4
$2K Buy
+25
New +$1.76K ﹤0.01% 477

Other funds holding HOLX

AlphaMark Advisors's HOLX Position: Q4 2023 in Review

AlphaMark Advisors sold out of Hologic (HOLX) in Q4 2023, closing a stake of 25 shares — an estimated $2K sold.

AlphaMark Advisors first reported a position in HOLX in Q4 2020 and held it in 12 quarters. The position peaked at $2K in Q3 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • AlphaMark Advisors reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • AlphaMark Advisors sold 25 Hologic shares in Q4 2023, an estimated $2K.
  • AlphaMark Advisors first reported a position in Hologic in Q4 2020 and held it in 12 quarters.
  • AlphaMark Advisors's Hologic position peaked at $2K in Q3 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on AlphaMark Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.